搜索筛选:
搜索耗时2.6272秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[期刊论文] 作者：Domenico Germano,Bruno Daniele,,
来源：World Journal of Gastroenterology 年份：2014
The management of hepatocellular carcinoma(HCC)has substantially changed in the past few decades,the introduction of novel therapies(such as sorafenib)have impr...
,TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angio
[期刊论文] 作者：Domenico Germano,Bruno Daniele,
来源：肝胆外科与营养 年份：2014
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide. In the past few years, the mechanisms of hepato-carcinogenesis...
[期刊论文] 作者：Massimo Di Maio,Bruno Daniele,,
来源：世界胃肠病学杂志：英文版（电子版） 年份：2008
在最近获得与的阳性结果前多指向酷氨酸激酶禁止者 sorafenib，为有先进肝细胞癌(HCC ) 的病人没有标准全身的治疗。性别荷尔蒙受体在 HCC 样品的一个重要比例被表示。支持在性...
[期刊论文] 作者：Massimo Di Maio,Bruno Daniele,Sandro Pignata,Ciro Gallo,Ermelinda De Maio,Alessandro Morabito,Maria Carmela,
来源：World Journal of Gastroenterology 年份：2008
Before the positive results recently obtained with multitarget tyrosine kinase inhibitor sorafenib,there was no standard systemic treatment for patients with ad...
[期刊论文] 作者：Massimo Di Maio,Bruno Daniele,Sandra Pignata,Ciro Gallo,Ermelinda De Maio,Alessandro Morabito,Maria Carmela,
来源：世界胃肠病学杂志（英文版） 年份：2008
Before the positive results recently obtained with multitarget tyrosine kinase inhibitor sorafenib, there was no standard systemic treatment for patients with a...
相关搜索：
